Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 9/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | JAK1 | P23458 | 1/20 | 0.34 |
| ▸ | TYK2 | P29597 | 1/20 | 0.34 |
| ▸ | JAK3 | P52333 | 1/20 | 0.34 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.34 |
| ▸ | CNR2 | P34972 | 2/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 5/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4719902 | 0.89 | IDO1 (0.40) | IDO1TRPV1SLC6A9P2RX7 | |
| SCHEMBL3545067 | 0.89 | NPC1 (0.41) | IDO1P2RX7 | |
| SCHEMBL4721261 | 0.87 | P2RX7 (0.38) | IDO1TRPV1SLC6A9P2RX7 | |
| SCHEMBL4721615 | 0.86 | IDO1 (0.36) | IDO1TRPV1SLC6A9P2RX7 | |
| SCHEMBL4721224 | 0.86 | IDO1 (0.36) | IDO1TRPV1JAK2JAK1SLC6A9 | |
| SCHEMBL4719738 | 0.86 | P2RX7 (0.37) | IDO1TRPV1CNR2P2RX7 | |
| SCHEMBL3535787 | 0.77 | SLC6A9 (0.60) | TRPV1SLC6A9 | |
| SCHEMBL4722312 | 0.76 | HDAC4 (0.42) | IDO1 | |
| SCHEMBL4721249 | 0.75 | SLC6A9 (0.56) | SLC6A9 | |
| SCHEMBL2047132 | 0.73 | CTSL (0.40) | IDO1SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1893566-A1 | CYCLOHEXANESULFONYL DERIVATIVES AS GLYT1 INHIBITORS TO TREAT SCHIZOPHRENIA | MERCK SHARP & DOHME LTD. (GB) | 2008-03-05 | — | — | EP | claimed |
| WO-2006131711-A1 | CYCLOHEXANESULFONYL DERIVATIVES AS GLYT1 INHIBITORS TO TREAT SCHIZOPHRENIA | MERCK SHARP & DOHME LIMITED (GB) | 2006-12-14 | — | — | WO | claimed |